Pharmaceutical industry
The global antifungal drugs market has exhibited moderate growth from 2015-2020, driven by increasing prevalence of fungal and nosocomial infections. According to a report, the market is expected to grow at a compound annual growth rate (CAGR) of around 4% from 2021-2026. The market is driven by the convenient availability
Pharmaceutical industry
The US FDA has authorized the first pill against COVID-19, a Pfizer drug called Paxlovid, which can be taken at home to prevent severe symptoms. The move comes as cases, hospitalizations, and deaths are rising, with health officials warning of a potential tsunami of new infections from the Omicron variant.
Pharmaceutical industry
The European Medicines Agency (EMA) has given the nod to the Novavax coronavirus vaccine, a protein-based shot that could be a game-changer in the fight against COVID-19. The vaccine, which uses a minuscule, look-alike version of the covid-19 spike protein, has proven to be safe and effective, with a 90.
Pharmaceutical industry
GlaxoSmithKline and Sanofi have announced positive results for their Covid-19 booster vaccine candidate, with consistently strong immune responses shown in a booster jab. The trial, the most comprehensive booster trial to date, explored boosting across different vaccine technologies used for primary vaccination. The companies plan to file the booster data
Pharmaceutical industry
The global multiple sclerosis (MS) drugs market is projected to grow from $21.27 billion in 2020 to $25.95 billion in 2025, driven by the increasing demand for effective treatments and the introduction of new products. The market is segmented by drug class, distribution channels, and route of administration.
Pharmaceutical industry
The global benign prostatic hyperplasia (BPH) treatment market was valued at $10.5 billion in 2020 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.6% from 2021 to 2026. The market is driven by the increasing prevalence of urological disorders, rising geriatric population, and
Pharmaceutical industry
The global benign prostatic hyperplasia (BPH) treatment market reached a value of US$ 10.5 Billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 5.6% during 2021-2026. The market is driven by the increasing prevalence of urological disorders, rising geriatric population, and
Pharmaceutical industry
Thrive Global, the leading behavior change technology company founded by Arianna Huffington, celebrated its fifth anniversary by launching the 5x5 product suite, a comprehensive set of five distinctive products available across five platforms. The new suite aims to address the growing stress and burnout epidemic, providing solutions to customers including
Pharmaceutical industry
Concerns about the emergence of the Omicron coronavirus variant have prompted vaccine manufacturers to accelerate the development of tailored shots. The rapid global response to the variant's spread has led countries to impose travel curbs and other restrictions, fueled by worries that it could spread quickly even among
Pharmaceutical industry
The Centers for Disease Control and Prevention (CDC) has updated its interim recommendations to make booster doses of the COVID-19 mRNA vaccines from Pfizer-BioNTech and Moderna available to tens of millions more fully vaccinated adults in the U.S. This change comes as the country heads into the winter months
Pharmaceutical industry
Millions of federal employees and contractors, including those working at the Transportation Security Administration, face a Monday deadline to provide proof of full COVID-19 vaccination, ahead of the Thanksgiving travel period. President Joe Biden ordered the mandate in September, requiring two doses of Pfizer or Moderna or the single shot
Pharmaceutical industry
As the holiday season approaches, a growing number of U.S. governors and officials are taking steps to expand access to COVID-19 boosters, despite federal guidance that only recommends them for certain high-risk groups. California made the first move, quietly instructing local health jurisdictions and vaccine providers to trust patients
